Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
HIV Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
HIV Infections Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1976 2017

Rifampin
Therapeutics
efavirenz
Pharmaceutical Preparations
Cytochrome P-450 CYP2B6

In Silico Dose Prediction for Long-Acting Rilpivirine and Cabotegravir Administration to Children and Adolescents

Rajoli, R. K. R., Back, D. J., Rannard, S., Meyers, C. F., Flexner, C., Owen, A. & Siccardi, M. May 24 2017 (Accepted/In press) In : Clinical Pharmacokinetics. p. 1-12 12 p.

Research output: Research - peer-reviewArticle

Rilpivirine
Computer Simulation
Pharmacokinetics
Injections
Weights and Measures

The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development

Smith, J. M. & Flexner, C. Jun 1 2017 In : AIDS. 31, p. S173-S184

Research output: Research - peer-reviewArticle

Polypharmacy
HIV
Population
Therapeutics
Drug Interactions

Universal antiretroviral regimens: thinking beyond one-pill-once-a-day

Jacobson, J. M. & Flexner, C. Mar 31 2017 (Accepted/In press) In : Current Opinion in HIV and AIDS.

Research output: Research - peer-reviewArticle

Monoclonal Antibodies
Pharmaceutical Preparations
Therapeutics
HIV Infections
HIV-1

Why a universal antiretroviral regimen?

Flexner, C. W., Clayden, P. & Venter, W. D. F. Jul 1 2017 In : Current Opinion in HIV and AIDS. 12, 4, p. 315-317 3 p.

Research output: Research - peer-reviewEditorial